Oncotarget Editor-in-Chief Wafik S. El-Deiry chairs 2025 WIN Symposium in collaboration with APM in Philadelphia
Business Announcement
Updates every hour. Last Updated: 15-Dec-2025 18:11 ET (15-Dec-2025 23:11 GMT/UTC)
BUFFALO, NY - October 1, 2025 – Oncotarget is proud to announce that its Editor-in-Chief, Wafik S. El-Deiry, MD, PhD, FACP, will chair the WIN Symposium as the Oncology Track of the Advancing Precision Medicine (APM) Annual Conference held October 3–4, 2025, at the Pennsylvania Convention Center in Philadelphia.
In what experts are calling a paradigm-shifting landmark study, scientists from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) report key findings about the underlying mechanisms of immune system stress response to protein misfolding, launching a new approach to cancer immunotherapy treatment targeting the protein production cycle.
In a major blow to public health, the Superior Court of California has ruled that the State of California may ignore the dangers of processed meat, a product that the World Health Organization has classified as “‘carcinogenic to humans’ (Group 1) on the basis of sufficient evidence for colorectal cancer.”
Cancer center researchers developed a safer, more targeted gene therapy to kill cancer cells linked to a common herpesvirus — potentially transforming treatment.
A Multi-Party Team represented by Carnegie Mellon University researchers and private industry partners has secured an award of up to $26.7 million from the Advanced Research Projects Agency for Health (ARPA-H) Platform Optimizing SynBio for Early Intervention and Detection in Oncology (POSEIDON) program to usher in a new era of proactive cancer screening, offering an at-home solution to detect over 30 Stage 1 solid tumor cancers from a simple urine sample.